Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

PDB3: EFFICACY OF INSULIN GLARGINE IN PATIENTS WITH TYPE 1 AND 2 DIABETES

Autor: Plauschinat, CA, Cryar, AK, Godley, PJ, Nguyen, AB

Publikováno v: In Value in Health 2003 6(3):327-328

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Precision Antiplatelet Therapy after Percutaneous Coronary Intervention (Precision PCI) Registry - Informing optimal antiplatelet strategies.

Autor: Cavallari LH; Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, College of Pharmacy, University of Florida, Gainesville, Florida, USA., Lee CR; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Division of Cardiology and McAllister Heart Institute, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Franchi F; Division of Cardiology, Department of Medicine, College of Medicine-Jacksonville, University of Florida, Jacksonville, Florida, USA., Keeley EC; Division of Cardiovascular Medicine, College of Medicine, University of Florida, Gainesville, Florida, USA., Rossi JS; Division of Cardiology and McAllister Heart Institute, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Thomas CD; Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, College of Pharmacy, University of Florida, Gainesville, Florida, USA., Gong Y; Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, College of Pharmacy, University of Florida, Gainesville, Florida, USA., McDonough CW; Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, College of Pharmacy, University of Florida, Gainesville, Florida, USA., Starostik P; Department of Pathology, Immunology and Laboratory Medicine; College of Medicine, University of Florida, Gainesville, Florida, USA., Al Saeed MJ; Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, College of Pharmacy, University of Florida, Gainesville, Florida, USA., Been L; Division of Cardiology, Department of Medicine, College of Medicine-Jacksonville, University of Florida, Jacksonville, Florida, USA., Kulick N; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Division of Cardiology and McAllister Heart Institute, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Malave J; Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, College of Pharmacy, University of Florida, Gainesville, Florida, USA., Mulrenin IR; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Nguyen AB; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Terrell JN; Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, College of Pharmacy, University of Florida, Gainesville, Florida, USA., Tillotson G; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Beitelshees AL; Department of Medicine and Program for Personalized and Genomic Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA., Winterstein AG; Department of Pharmaceutical Outcomes & Policy and Center for Drug Evaluation and Safety, College of Pharmacy, University of Florida, Gainesville, Florida, USA., Stouffer GA; Division of Cardiology and McAllister Heart Institute, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Angiolillo DJ; Division of Cardiology, Department of Medicine, College of Medicine-Jacksonville, University of Florida, Jacksonville, Florida, USA.

Publikováno v: Clinical and translational science [Clin Transl Sci] 2024 Aug; Vol. 17 (8), pp. e70004.

CYP2C19 Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary Intervention.

Autor: Tunehag KR; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill NC USA., Thomas CD; Department of Pharmacotherapy & Translational Research and Center for Pharmacogenomics and Precision Medicine College of Pharmacy, University of Florida Gainesville FL USA., Franchi F; Division of Cardiology, Department of Medicine College of Medicine-Jacksonville, University of Florida Jacksonville FL USA., Rossi JS; Division of Cardiology and McAllister Heart Institute, School of Medicine University of North Carolina at Chapel Hill Chapel Hill NC USA., Keeley EC; Division of Cardiovascular Medicine College of Medicine, University of Florida Gainesville FL USA., Anderson RD; Division of Cardiovascular Medicine College of Medicine, University of Florida Gainesville FL USA., Beitelshees AL; University of Maryland School of Medicine Department of Medicine and Program for Personalized and Genomic Medicine Baltimore MD USA., Duarte JD; Department of Pharmacotherapy & Translational Research and Center for Pharmacogenomics and Precision Medicine College of Pharmacy, University of Florida Gainesville FL USA., Gong Y; Department of Pharmacotherapy & Translational Research and Center for Pharmacogenomics and Precision Medicine College of Pharmacy, University of Florida Gainesville FL USA., Kerensky RA; Division of Cardiovascular Medicine College of Medicine, University of Florida Gainesville FL USA., McDonough CW; Department of Pharmacotherapy & Translational Research and Center for Pharmacogenomics and Precision Medicine College of Pharmacy, University of Florida Gainesville FL USA., Nguyen AB; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill NC USA., Ortega-Paz L; Division of Cardiology, Department of Medicine College of Medicine-Jacksonville, University of Florida Jacksonville FL USA., Venkatesh S; Division of Cardiology, Duke Department of Medicine Duke University School of Medicine Durham NC USA., Wang Y; Department of Pharmaceutical Outcomes & Policy, Department of Epidemiology, and Center for Drug Evaluation and Safety University of Florida Gainesville FL USA., Johnson JA; Department of Pharmacotherapy & Translational Research and Center for Pharmacogenomics and Precision Medicine College of Pharmacy, University of Florida Gainesville FL USA.; Division of Cardiovascular Medicine College of Medicine, University of Florida Gainesville FL USA., Winterstein AG; Department of Pharmaceutical Outcomes & Policy, Department of Epidemiology, and Center for Drug Evaluation and Safety University of Florida Gainesville FL USA., Stouffer GA; Division of Cardiology and McAllister Heart Institute, School of Medicine University of North Carolina at Chapel Hill Chapel Hill NC USA., Angiolillo DJ; Division of Cardiology, Department of Medicine College of Medicine-Jacksonville, University of Florida Jacksonville FL USA., Cavallari LH; Department of Pharmacotherapy & Translational Research and Center for Pharmacogenomics and Precision Medicine College of Pharmacy, University of Florida Gainesville FL USA., Lee CR; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill NC USA.; Division of Cardiology and McAllister Heart Institute, School of Medicine University of North Carolina at Chapel Hill Chapel Hill NC USA.

Publikováno v: Journal of the American Heart Association [J Am Heart Assoc] 2024 Jun 18; Vol. 13 (12), pp. e033791. Date of Electronic Publication: 2024 Jun 14.